Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗胆固醇血症药(Anticholesteremic Agents);心血管疾病(Cardiovascular Diseases);费用效益分析(Cost-Benefit Analysis);药费支出(Drug Costs);女(雌)性(Female);卫生保健费用(Health Care Costs);住院(Hospitalization);人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);男(雄)性(Male);中年人(Middle Aged);随机对照试验(主题)(Randomized Controlled Trials as Topic);危险因素(Risk Factors);斯伐他汀(Simvastatin)
DOI
10.1016/S0140-6736(05)63014-0
PMID
15910950
发布时间
2016-11-24
- 浏览15
Lancet (London, England)
1779-85页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文